Insider Shareholders with Direct Ownership of Zosano Pharma Corp (ZSANQ)
This section provides a comprehensive overview of the insiders with direct ownership of Zosano Pharma Corp (ZSANQ). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Zosano Pharma Corp Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Donald J Kellerman
VP, Clinical Dev & Med Affairs |
42,500 | 5,715 | 56,331 $0 | 4 |
Mar 31, 2022
Reduced 6.64%
|
|
Hayley Lewis
Officer |
32,500 | 1,709 | 49,779 $0 | 2 |
Jun 04, 2021
Reduced 3.32%
|
|
Kenneth Greathouse
Director |
36,000 | 10,000 | 43,500 $0 | 3 |
Nov 23, 2021
Reduced 18.69%
|
|
Kleanthis G Xanthopoulos
Director |
15,000 | 0 | 23,596 $0 | 1 |
Jun 10, 2021
Added 38.86%
|
|
Linda Grais
Director |
15,000 | 0 | 22,500 $0 | 1 |
Jun 10, 2021
Added 40.0%
|
|
Joseph P Hagan
Director |
15,000 | 0 | 22,500 $0 | 1 |
Jun 10, 2021
Added 40.0%
|
|
Steve Elms
Director |
15,000 | 0 | 22,500 $0 | 1 |
Jun 10, 2021
Added 40.0%
|
|
Steven Lo
Chief Executive Officer |
351,250 | 37,233 | 13,163 $0 | 5 |
Jun 06, 2022
Reduced 3.25%
|
|
Christine Matthews
Chief Financial Officer |
137,500 | 9,907 | 4,183 $0 | 5 |
Jun 06, 2022
Reduced 1.92%
|